Clincosm LogoSign in Get a demo

antibiotic: Safety of Antibiotic Intake During Pregnancy

Sponsor
Al-Azhar University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05810935
Collaborator
(none)
384
Enrollment
12
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

this study will be conducted to assess the knowledge of the pregnant females regarding safety of antibiotic intake ,also their attitude toward any prescribed antibiotics during their pregnancy .

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    this study will be conducted on pregnant females from two Arab countries to assess their knowledge and attitude toward any prescribed antibiotics while they are pregnant .Also to assess any malpractice while their intake for any antibiotics . this study is a cross sectional study that will involve a questionnaire including the three mentioned domains .

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    384 participants
    Observational Model:
    Other
    Time Perspective:
    Cross-Sectional
    Official Title:
    Safety of Antibiotic Intake During Pregnancy: Results of Questionnaire of Pregnant Women in Two Arab Countries
    Anticipated Study Start Date :
    May 1, 2023
    Anticipated Primary Completion Date :
    Jan 1, 2024
    Anticipated Study Completion Date :
    May 1, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Number of participants with antibiotic-related side effects [through study completion ,an average of one year]

      using a questionnaire to measure the knowledge and attitude of pregnant women toward antibiotics that were taken during pregnancy and any malpractice during its intake

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • pregnant women at any gestational age
    Exclusion Criteria:
    • pregnant women who refused to participate

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Al-Azhar University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Eman Ibrahim Abd Elrehim, Lecturer in Department of obstetrics and gynecology, Damietta Faculty of Medicine, Al-Azhar University, Al-Azhar University
    ClinicalTrials.gov Identifier:
    NCT05810935
    Other Study ID Numbers:
    • DFM-IRB 00012367-23-03-004
    First Posted:
    Apr 13, 2023
    Last Update Posted:
    Apr 13, 2023
    Last Verified:
    Apr 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Eman Ibrahim Abd Elrehim, Lecturer in Department of obstetrics and gynecology, Damietta Faculty of Medicine, Al-Azhar University, Al-Azhar University
    antibiotics, infection
    Additional relevant MeSH terms:
    Infections

    Study Results

    No Results Posted as of Apr 13, 2023